Yaohai Bio

About:

Yaohai Bio is a genetic engineering protein drug developer

Top Investors: Qiandao Fund, CICC Qide, Wuhan Renfu Biomedical Industry Investment Fund Center

Description:

Yaohai Biotechnology Co., Ltd. is a genetic engineering protein drug developer, dedicated to contracting services for biotechnology products, and building an open, all-round, integrated production and research service platform for biological products CRO/CMO/MAH.

Total Funding Amount:

150M CNY

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2010-08-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-11-21

IPO Status:

Private

Industries: